Bipolar Ii Disorder
📧 Sign up to get email alerts when something new happens for Bipolar Ii Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-06Clinical Trial Update: Assessment of Acute Psychomotor Agitation Measures Associated With Schizophrenia and Bipolar Disorder [Phase 2]
Phase 2 clinical trial assessing measures of acute psychomotor agitation in people with schizophrenia and bipolar disorder has completed. Th…
-
CLINICAL_TRIALS trial_result · 2026-03-30Clinical Trial Update: To Evaluate the Effects of NMRA-335140 on Symptoms of Major Depression in Participants With Bipolar II Disorder. [Phase 2]
This Phase 2 trial evaluated NMRA-335140 for depressive symptoms in Bipolar II disorder. The study status is completed.
-
CLINICAL_TRIALS trial_result · 2026-03-05Clinical Trial Update: Ketamine for Treatment-Resistant Bipolar Disorder [Phase 2]
A Phase 2 clinical trial evaluating ketamine for treatment-resistant bipolar disorder has completed.
-
CLINICAL_TRIALS trial_result · 2026-03-05Clinical Trial Update: Maintenance Ketamine Infusions for Treatment-Resistant Bipolar Depression [Phase 2]
A Phase 2 completed trial update evaluating maintenance ketamine infusions for treatment-resistant bipolar depression.
-
CLINICAL_TRIALS trial_result · 2026-01-12Clinical Trial Update: Study of Oral ABBV-932 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Bipolar I or II Disorder [Phase 2]
Phase 2 trial update for ABBV-932 in adults with Bipolar I or Bipolar II disorder, assessing adverse events and changes in disease activity;…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-09-18Clinical Trial Update: Dexmedetomidine in the Treatment of Agitation Associated With Schizophrenia and Bipolar Disorder (SERENITY III) [Phase 3]
Phase 3 trial evaluating dexmedetomidine for agitation associated with schizophrenia and bipolar disorder has completed.
-
CLINICAL_TRIALS trial_result · 2025-03-17Clinical Trial Update: Efficacy of the Mobile Application for Prediction and Prevention of Mood Episode Recurrence Based on Machine Learning [NA]
A completed clinical trial evaluating the efficacy of a machine-learning-based mobile app to predict and prevent mood episode recurrence in …
-
CLINICAL_TRIALS trial_result · 2025-02-18Clinical Trial Update: Phase 2 Clinical Trial of GH001 in Bipolar II Disorder [Phase 2]
A Phase 2 study of GH001 in Bipolar II Disorder has been terminated, ending the trial.
-
CLINICAL_TRIALS trial_result · 2024-11-18Clinical Trial Update: Synaptic Imaging and Network Activity in Treatment Resistant Depression [NA]
King's College London completed a clinical trial investigating synaptic imaging and network activity in treatment-resistant depression.
-
CLINICAL_TRIALS trial_result · 2024-11-04Clinical Trial Update: Efficacy of Convulsive Therapies for Bipolar Depression [NA]
A completed clinical trial evaluating the efficacy of convulsive therapies for bipolar depression, sponsored by the Centre for Addiction and…
-
CLINICAL_TRIALS trial_result · 2024-06-26Clinical Trial Update: Evaluating the Hypothesized Mechanism of Action of N-acetylcysteine for Bipolar Disorder [Phase 2]
Phase 2 trial evaluating N-acetylcysteine for Bipolar Disorder has completed; results were posted on 2024-06-26.
-
CLINICAL_TRIALS trial_result · 2023-02-22Clinical Trial Update: Differential Responses to Drugs and Sweet Tastes [Phase 1]
Phase 1 clinical trial investigating differential responses to drugs and sweet tastes in Bipolar II Disorder; study completed with results p…
-
CLINICAL_TRIALS trial_result · 2022-10-25Clinical Trial Update: The Safety and Efficacy of Psilocybin in Participants With Type 2 Bipolar Disorder (BP-II) Depression. [Phase 2]
Phase 2 trial update evaluating safety and efficacy of psilocybin for treatment-resistant depression in adults with bipolar II disorder.
-
CLINICAL_TRIALS trial_result · 2021-03-09Clinical Trial Update: add-on Low Dose Memantine in Middle-to-old Aged Bipolar II Disorder Patients [Phase 2, Phase 3]
A clinical trial investigating add-on low-dose memantine for bipolar II disorder in middle-to-older adults, spanning Phase 2 and Phase 3.
-
CLINICAL_TRIALS trial_result · 2020-11-13Clinical Trial Update: Gabapentin for Bipolar & Cannabis Use Disorders [Phase 2]
Phase 2 clinical trial investigating gabapentin for bipolar disorder and cannabis use disorders has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-08-14Clinical Trial Update: Sequential Multiple Assignment Treatment for Bipolar Disorder [Phase 4]
Phase 4 clinical trial update on sequential multiple assignment treatment for bipolar disorder (bipolar I and II) completed with results pos…
-
CLINICAL_TRIALS trial_result · 2019-01-25Clinical Trial Update: Efficacy and Tolerability Study of Betahistine to Ameliorate Antipsychotic Associated Weight Gain [Phase 2]
Phase 2 trial evaluating betahistine for efficacy and tolerability in reducing antipsychotic-associated weight gain; the study is completed …
-
CLINICAL_TRIALS trial_result · 2018-03-15Clinical Trial Update: Tranylcypromine Treatment of Bipolar Depression [Phase 4]
Phase 4 study of tranylcypromine for bipolar depression has completed, with results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2017-09-27Clinical Trial Update: Seroquel in the Treatment of Dysphoric Hypomania in Bipolar II [Phase 4]
Phase 4 trial evaluating Seroquel for dysphoric hypomania in Bipolar II Disorder has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2017-07-26Clinical Trial Update: Effect of Ketamine vs. Active Placebo on Suicidal Ideation in Depressed Inpatients With Major Depressive Disorder or Bipolar Depression. [EARLY_Phase 1]
An early-phase 1 trial comparing ketamine to an active placebo in depressed inpatients (major depressive disorder or bipolar disorder with d…
-
CLINICAL_TRIALS trial_result · 2017-07-25Clinical Trial Update: Prevention of Weight Gain in Early Psychoses [NA]
A completed clinical trial update examining strategies to prevent weight gain in individuals with early psychosis.
-
CLINICAL_TRIALS trial_result · 2017-05-17Clinical Trial Update: Study of Lurasidone in Treating Antipsychotic Naive or Quasi-Naive Children and Adolescents [Phase 2]
Phase 2 study evaluating lurasidone in antipsychotic-naive or quasi-naive children and adolescents with schizophrenia-spectrum and mood diso…
-
CLINICAL_TRIALS trial_result · 2017-04-25Clinical Trial Update: Ginger.io Behavioral Health Study [NA]
The Ginger.io Behavioral Health Study (NCT02491307), sponsored by Community Health Center, Inc., has been terminated and involved anxiety, d…
-
CLINICAL_TRIALS trial_result · 2017-04-19Clinical Trial Update: Psychotherapy for Bipolar II Depression, Pilot Study, Phase II [Phase 2, Phase 3]
A pilot psychotherapy study for Bipolar II Disorder completed Phase II/III (Phase II and Phase III) with results posted.
-
CLINICAL_TRIALS trial_result · 2016-12-19Clinical Trial Update: Evaluating the Efficacy of Adjunctive Minocycline for the Treatment of Bipolar Depression [Phase 3]
Phase 3 clinical trial evaluating adjunctive minocycline for bipolar depression has completed.